Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase*

Hyperhomocyst(e)inemia is believed to injure endothelial cells in vivo through a number of mechanisms, including the generation of hydrogen peroxide (H2O2). Earlier in vitro studies demonstrated that homocyst(e)ine (Hcy) decreases the biological activity of endothelium-derived relaxing factor and that this decrease can be reversed by preventing the generation of hydrogen peroxide. Here we show that Hcy treatment of bovine aortic endothelial cells leads to a dose-dependent decrease in NO x (p = 0.001 by one-way analysis of variance) independent of endothelial nitric-oxide synthase activity or protein levels and nos3 transcription, suggesting that Hcy affects the bioavailability of NO, not its production. We hypothesized that, in addition to increasing the generation of H2O2, Hcy decreases the cell’s ability to detoxify H2O2 by impairing intracellular antioxidant enzymes, specifically the intracellular isoform of glutathione peroxidase (GPx). To test this hypothesis, confluent bovine aortic endothelial cells were treated with a range of concentrations of Hcy, and intracellular GPx activity was determined. Compared with control cells, cells treated with Hcy showed a significant reduction in GPx activity (up to 81% at 250 μm Hcy). In parallel with the decrease in GPx activity, steady-state GPx mRNA levels were also significantly decreased compared with control levels after exposure to Hcy, which appeared not to be a consequence of message destabilization. These data suggest a novel mechanism by which Hcy, in addition to increasing the generation of hydrogen peroxide, may selectively impair the endothelial cell’s ability to detoxify H2O2, thus rendering NO more susceptible to oxidative inactivation.

[1]  C. Sobey,et al.  Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. , 1996, The Journal of clinical investigation.

[2]  J. Loscalzo,et al.  S-nitrosothiol detection. , 1996, Methods in enzymology.

[3]  S. Fujii,et al.  Inactivation of Glutathione Peroxidase by Nitric Oxide , 1995, The Journal of Biological Chemistry.

[4]  J. Loscalzo,et al.  Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. , 1995, The Journal of clinical investigation.

[5]  A. Lindgren,et al.  Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. , 1995, Clinical chemistry.

[6]  T. Ogihara,et al.  Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[7]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Rodgers,et al.  Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  K. Hajjar.  Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. , 1993, The Journal of clinical investigation.

[10]  A. Buczyński,et al.  Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. , 1993, Atherosclerosis.

[11]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.

[12]  P. Tempst,et al.  Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[14]  M. Malinow.  Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. , 1990, Circulation.

[15]  P. Newburger,et al.  Isolation and chromosomal localization of the human glutathione peroxidase gene. , 1990, Genomics.

[16]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Ewing,et al.  Oxy-radicals in Molecular Biology and Pathology , 1989 .

[18]  L. Taylor,et al.  Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. , 1989, Circulation.

[19]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[20]  J. Whitin,et al.  Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine plasma glutathione peroxidase protein and selenium content in plasma. , 1989, Blood.

[21]  I. Fridovich,et al.  Oxy-Radicals in Molecular Biology and Pathology , 1988 .

[22]  B. Israelsson,et al.  Homocysteine and myocardial infarction. , 1988, Atherosclerosis.

[23]  F. Lindgärde,et al.  Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. , 1988, Metabolism: clinical and experimental.

[24]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[25]  M. Norusis,et al.  Homocysteinemia due to folate deficiency. , 1987, Metabolism: clinical and experimental.

[26]  G. Rodgers,et al.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. , 1986, The Journal of clinical investigation.

[27]  K.,et al.  Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. , 1986, The Journal of clinical investigation.

[28]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[29]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[30]  J. Hardebo,et al.  Moderate Homocysteinemia - A Possible Risk Factor For Arteriosclerotic Cerebrovascular Disease , 1984, Stroke.

[31]  A. Tappel,et al.  Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. , 1984, The Journal of biological chemistry.

[32]  T. Crenshaw,et al.  Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B-6: relationship to atherosclerosis. , 1983, The Journal of nutrition.

[33]  P. Puska,et al.  ASSOCIATION BETWEEN CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION AND SERUM SELENIUM IN A MATCHED-PAIR LONGITUDINAL STUDY , 1982, The Lancet.

[34]  J. Opstvedt,et al.  Availability of selenium in fish meal in comparison with soybean meal, corn gluten meal and selenomethionine relative to selenium in sodiumselenite for restoring glutathione peroxidase activity in selenium-depleted chicks. , 1980, The Journal of nutrition.

[35]  G. Striker,et al.  Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. , 1980, Thrombosis research.

[36]  R. Ross,et al.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. , 1976, The Journal of clinical investigation.

[37]  J. Folkman,et al.  Human vascular endothelial cells in culture. Lack of response to serum growth factors. , 1976, Experimental cell research.

[38]  S. Agarwal,et al.  Letter: Alpha-fetoprotein in Indian childhood cirrhosis. , 1974, Lancet.

[39]  E. Jaffe,et al.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells. , 1973, The Journal of clinical investigation.

[40]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[41]  G. Ehrlich,et al.  The Metabolic Basis Of Inherited Disease. , 1973 .

[42]  J. Finkelstein,et al.  Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. , 1972, Biochemical and biophysical research communications.

[43]  A. George.  The metabolic basis of inherited disease , 1961 .